Detecting the presence of liquid in a vibrating membrane nebulizer

The method addresses errors in liquid detection by intermittently driving the vibrating device and comparing spectra during inhalation and non-inhalation periods, ensuring reliable liquid detection and preventing membrane damage in vibrating membrane nebulizers.

JP7596541B2Active Publication Date: 2024-12-09VECTURA DELIVERY DEVICES LTD
View PDF 14 Cites 0 Cited by

Patent Information

Application Number
JP2023537143
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-12-16
Filing Date
2021-12-15
Publication Date
2024-12-09
Estimated Expiration
2041-12-15

AI Technical Summary

Technical Problem

Existing methods for detecting the presence of liquid in vibrating membrane nebulizers are prone to errors due to changes in the electromechanical behavior of the aerosol generator and drive electronics, leading to potential membrane damage or incomplete dose delivery.

Method used

An improved method that intermittently drives the vibrating device during patient inhalation and non-inhalation periods, measuring electrical parameters at multiple frequencies to compare spectra before and after aerosol generation, utilizing transient effects from standing wave formation and dissipation to reliably detect liquid presence.

Benefits of technology

This approach is robust to hardware and environmental changes, ensuring accurate detection of liquid absence and preventing membrane damage or incomplete dosing by stopping vibration when necessary.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007596541000001
    Figure 0007596541000001
  • Figure 0007596541000002
    Figure 0007596541000002
  • Figure 0007596541000003
    Figure 0007596541000003
Patent Text Reader

Abstract

The present invention provides a breath actuated inhalation device comprising an aerosol generating device comprising a vibration device and a membrane, and a reservoir for liquid to be aerosolized in fluid communication with the membrane. A method for operating the device is also provided. The vibration device is driven intermittently such that the aerosol generating device has periods of aerosol generation during a patient's inhalation and periods of little or no aerosol generation before and / or after inhalation. A scan is performed in which electrical parameters of the vibration device are measured as the membrane is vibrated at multiple frequencies. A spectrum obtained from the scan during inhalation is compared to a spectrum obtained from a scan during a period before or after inhalation to determine whether liquid is present in the reservoir.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to vibrating membrane nebulizers, and in particular to a method for detecting the presence of liquid in contact with the membrane. [Background technology]

[0002] Aerosols for medical inhalation therapy generally contain an active ingredient dissolved or suspended in an aerosolizable liquid, which is often water. A uniform distribution of aerosol droplets with a droplet size of about 5 μm is required to reach deep into the lungs. Vibrating membrane nebulizers are a type of device for generating such aerosols. These devices have an aerosol generator that includes a vibrating device, such as a piezoelectric element that is excited at ultrasonic frequencies to induce vibrations, a membrane (sometimes called a mesh or aperture plate) with a large number of holes, typically with a diameter of 1 μm to 10 μm, and a reservoir that supplies the liquid formulation to the membrane.

[0003] Continuing to operate a vibrating membrane nebulizer after the liquid reservoir has been emptied can crack or damage the membrane. Therefore, it is important to be able to reliably detect whether liquid is present in the reservoir / in contact with the membrane ("empty detection"). When the liquid is exhausted, the nebulizer can prompt the patient for the end of the treatment time and / or automatically turn off the vibrating device.

[0004] One approach is to simply measure the amount of liquid in the reservoir with a suitable sensor. For example, US Pat. No. 5,399,433 discloses a nebulizer in which the amount of liquid in the reservoir is sensed by a piezoelectric, optical, conductivity, or strain gauge sensor. However, this requires a dedicated sensor, which adds cost and complexity to the device, and the sensor may need to be in contact with the liquid, which can be problematic.

[0005] An alternative approach exploits the fact that the vibration characteristics (e.g., resonant frequency, power consumption, etc.) of the aerosol generating device are typically quite different when the membrane is in contact with a liquid compared to when the membrane is dry. For example, US Pat. No. 5,399,433 discloses a nebulizer that determines whether liquid is present by comparing the detected value of an electrical parameter (e.g., current to a piezoelectric element) at a particular frequency with a stored value. US Pat. No. 5,399,433 uses impedance measurements in a similar approach. Instead of using a single frequency, the electromechanical behavior of the aerosol generating device can be represented as a spectrum, for example, a graph of power or current consumption as a function of vibration frequency. US Pat. Nos. 5,499,433 and 5,499,433 disclose methods for comparing measured spectra with stored spectra using averaging and various mathematical techniques to improve the reliability of empty detection. The comparison is typically performed at regular intervals while the membrane is vibrated for the treatment time until it is determined that all the liquid has been used up. [Prior art documents] [Patent documents]

[0006] [Patent Document 1] US Patent Application Publication No. 2006 / 0255174 [Patent Document 2] US Patent Application Publication No. 2006 / 0102172 [Patent Document 3] U.S. Patent No. 9,272,101 [Patent Document 4] International Publication No. 2014 / 062175 [Patent Document 5] International Publication No. 2015 / 091356 [Patent Document 6] European Patent Application Publication No. 2724741 [Patent Document 7] International Publication No. 2013 / 098334 [Patent Document 8] International Publication No. 2008 / 058941 [Patent Document 9] International Publication No. 2012 / 046220 [Patent Document 10] International Publication No. 2015 / 193432 [Patent Document 11] U.S. Patent No. 9,027,548 Summary of the Invention [Problem to be solved by the invention]

[0007] However, inherent vibrations in the hardware components of the nebulizer (e.g., aerosol generator, driver electronics) and / or changes in those inherent vibrations over the life of the nebulizer or due to changes in external conditions such as ambient temperature can affect the electromechanical behavior. For example, methods that rely on comparison to preset values ​​can produce erroneous results if the characteristics of the aerosol generator and / or driver electronics differ from the characteristics on which the standard stored values ​​are based. As a result, the vibration device may continue to vibrate after the liquid is depleted, which can damage the membrane, or vibration may be stopped while liquid still remains unaerosolized, so that the entire dose is not delivered to the patient. Thus, there remains a need for improved methods to reliably detect the presence of liquid in the reservoir and / or in contact with the membrane. [Means for solving the problem]

[0008] The present invention provides an improved method for determining when the liquid to be nebulized is exhausted. The inventors have recognized that transient effects can be observed in the spectrum immediately after the start or stop of vibration, and that these can be used to reliably detect the presence or absence of liquid in contact with the membrane. Thus, in a first aspect, the present invention provides a breath-actuated inhalation device comprising an aerosol generating device having a vibration device and a membrane, a reservoir for the liquid to be aerosolized in fluid communication with the membrane, and a control device providing a drive signal to drive the vibration device so that the membrane vibrates to generate an aerosol, the control device comprising: intermittently driving the vibration device such that the aerosol generating device alternates between periods of aerosol generation during a patient's inhalation and periods of little or no aerosol generation before and / or after inhalation; vibrating the membrane at a plurality of frequencies and performing a scan in which at least one electrical parameter of the vibrating device is measured at the plurality of frequencies to provide a spectrum, the scans being performed during inhalation and during periods before and after inhalation; comparing the spectrum obtained during inhalation with spectra obtained during periods before or after said inhalation; determining whether liquid is present in the reservoir based on the comparison of the spectra; and ceasing to activate the vibration device if the control device determines that no liquid is present; and The present invention provides an inhalation device configured to:

[0009] Previous empty detection methods, which measure the value of an electrical parameter while vibrating the membrane, rely on changes in the electromechanical properties of the aerosol generating device as the volume of liquid decreases over time. In contrast, the present invention relies on effects that occur when vibrating the membrane intermittently, such as in a breath-actuated nebulizer. The present invention compares spectra obtained during periods of aerosol generation with spectra obtained during periods of little or no aerosol generation to identify changes resulting from the formation or dissipation of standing waves in the reservoir when vibration is started or stopped, respectively. The present invention is much less dependent on the properties of the aerosol generating device than previous methods, for example, since it does not rely on comparison with stored spectra, but instead detects temporary changes that occur only when liquid is present. As a result, the present invention is more robust to changes in hardware, changes in hardware over the life of the nebulizer, and changes in external conditions.

[0010] The control device may be configured to perform a first scan before each inhalation or period of aerosol generation to obtain a first spectrum, subsequently perform a second scan during each inhalation or period of aerosol generation to obtain a second spectrum, and compare the first spectrum with the second spectrum. The first scan may be performed immediately before the start of the period of aerosol generation. The second scan may be performed at least 50 ms or 100 ms after the start of the period of aerosol generation. This provides enough time for a standing wave to form so that it is detectable in the second scan. The second scan may be performed less than 1000 ms or less than 500 ms after the start of the period of aerosol generation. The time delay between the first scan and the second scan determines when the absence of liquid can be detected. A smaller delay results in earlier empty detection, so that the vibration of the membrane can be stopped earlier.

[0011] The inhalation device is breath-actuated, i.e. aerosol is not generated continuously, but only when the patient inhales. The device may comprise a passageway having an air inlet opening and an aerosol outlet opening, and a pressure sensor pneumatically coupled to the passageway, and the controller may be configured to receive a signal from the pressure sensor, detect inhalation by the patient at the aerosol outlet opening based on the signal from the pressure sensor, and initiate a period of aerosol generation in response to inhalation. The controller may be configured to initiate a period of little or no aerosol generation at a preset time after the period of aerosol generation has been initiated. Alternatively, the controller may be configured to detect when the patient stops inhaling based on the signal from the pressure sensor, and initiate a period of little or no aerosol generation in response to the cessation of inhalation. The method of the present invention is particularly suited to breath-actuated nebulizers, since aerosol generation is essentially intermittent, and therefore no changes to the manner in which the nebulizer operates are required.

[0012] The aerosol generating device may comprise a support member on which the vibration device and / or the membrane are mounted. The vibration device may be an annular piezoelectric element. The support element may be a transducer in the form of a hollow tubular body having a flange at or near a first end to which the piezoelectric element is attached and at or near a second end to which the membrane is mounted. The device may comprise a filling chamber located above and in fluid communication with the support member such that the filling chamber and the hollow tubular body together form a reservoir. Alternatively, the support member may comprise an essentially planar annulus or disc, and the membrane and / or the vibration device may be mounted to the support member, for example on both sides.

[0013] The control device may be configured to determine the resonant frequency of the aerosol generation device from the spectrum and to drive the vibration device at the resonant frequency or at a frequency related to the resonant frequency, such as a fixed offset from the resonant frequency, during periods of aerosol generation other than scanning.

[0014] The multiple frequencies can include frequencies from about 10 kHz or about 15 kHz below the resonant frequency to about 10 kHz or about 15 kHz above the resonant frequency, for example, from about 75 kHz to about 100 kHz.

[0015] The control device may be configured to perform the comparison of the spectra by calculating an overlap function. The control device may be further configured to determine that no liquid is present in the reservoir if the value of the overlap function exceeds a threshold value. The control device may also be configured to stop driving the vibration device if the overlap function exceeds a threshold value for a period of multiple consecutive inhalations or aerosol generation, such as a period of three or five inhalations or three or five aerosol generation. The overlap function provides a robust comparison method.

[0016] In a second aspect, the present invention provides a method of operating an inhalation device of the first aspect of the invention and / or a method of operating a breath actuated inhalation device comprising an aerosol generation device having a vibration device and a membrane, and a reservoir for liquid to be aerosolized, in fluid communication with the membrane, comprising: a) intermittently driving a vibration device such that the aerosol generating device alternates between periods of aerosol generation during a patient's inhalation and periods of little or no aerosol generation before and / or after inhalation; b) vibrating the membrane at multiple frequencies and performing a scan in which at least one electrical parameter of the vibrating device is measured at the multiple frequencies to provide a spectrum, the scans being performed during inhalation and during periods of little or no aerosol generation; c) comparing the spectrum obtained during the inhalation with spectra obtained during periods before or after said inhalation; d) determining whether liquid is present in the reservoir based on the comparison of the spectra; e) ceasing to activate the vibration device if it is determined in step d) that no liquid is present; The present invention provides a method comprising:

[0017] A first scan can be performed before each inhalation to obtain a first spectrum, and a second scan can be performed subsequently during each inhalation to obtain a second spectrum, and the first and second spectra can be compared.

[0018] The inhalation device comprises a passageway having an air inlet opening and an aerosol outlet opening, and a pressure sensor pneumatically coupled to the passageway, and the period of aerosol generation may be initiated in response to inhalation by the patient based on a signal from the pressure sensor. The period of little or no aerosol generation may be initiated at a preset time after the period of aerosol generation has begun. Alternatively, the period of little or no aerosol generation may be initiated in response to cessation of inhalation by the patient.

[0019] The spectra can be compared by calculating an overlap function. If the overlap function exceeds a threshold, it can be determined that there is no liquid in the reservoir. Driving the vibration device can be stopped if the overlap function exceeds a threshold for a period of multiple consecutive inhalations or aerosol generation, such as a period of three or five inhalations or three or five aerosol generation.

[0020] In certain embodiments, the present invention provides a breath actuated inhalation device comprising an aerosol generation device having a vibration device and a membrane, a reservoir for a liquid to be aerosolized in fluid communication with the membrane, and a controller providing a drive signal to drive the vibration device such that the membrane vibrates to generate an aerosol in a passageway, the controller comprising: intermittently driving the vibration device such that the aerosol generating device alternates between periods of aerosol generation during a patient's inhalation and periods of little or no aerosol generation before and / or after inhalation; performing a first scan immediately prior to or at the start of each inhalation or period of aerosol generation, vibrating the membrane at a plurality of frequencies and measuring at least one electrical parameter of the vibrating device for each of the plurality of frequencies to provide a first spectrum; Subsequent during each inhalation or aerosol generation period, vibrating the membrane at a plurality of frequencies and performing a second scan in which at least one electrical parameter of the vibrating device is measured for each of the plurality of frequencies to provide a second spectrum; performing a comparison between the first spectrum and the second spectrum; determining whether liquid is present in the reservoir based on a comparison of the first spectrum and the second spectrum; and ceasing to activate the vibration device if the control device determines that no liquid is present; and The present invention provides a breath actuated inhalation device configured to:

[0021] The present invention relates to a method of operating a breath actuated inhalation device according to this particular embodiment, comprising the steps of: a) intermittently driving a vibration device such that the aerosol generating device alternates between periods of aerosol generation during a patient's inhalation and periods of little or no aerosol generation before and / or after inhalation; b) immediately prior to or at the start of each inhalation or period of aerosol generation, vibrating the membrane at a plurality of frequencies and performing a first scan in which at least one electrical parameter of the vibrating device is measured for each of the plurality of frequencies to provide a first spectrum; c) subsequently during each inhalation or aerosol generation period, vibrating the membrane at a plurality of frequencies and performing a second scan in which at least one electrical parameter of the vibrating device is measured for each of the plurality of frequencies to provide a second spectrum; d) performing a comparison between the first spectrum and the second spectrum; e) determining whether liquid is present in the reservoir based on a comparison of the first spectrum and the second spectrum; and f) ceasing to activate the vibration device if it is determined in step e) that no liquid is present; A method is also provided, including:

[0022] The invention will now be further explained with reference to the figures. [Brief description of the drawings]

[0023] [Figure 1] FIG. 2 is an exploded view of a vibrating membrane nebulizer. [Diagram 2] FIG. 2 is a cross-sectional view of an aerosol generating device for the nebulizer of FIG. [Diagram 3] FIG. 1 is a schematic diagram of a drive circuit for an aerosol generating device. [Figure 4A] FIG. 13 is a schematic diagram of the liquid surface in the reservoir before vibration of the membrane. [Figure 4B] FIG. 13 is a schematic diagram of the liquid surface in the reservoir during vibration of the membrane. [Diagram 5] The spectrum was taken when there was no liquid in the reservoir. [Figure 6] The spectrum was taken when liquid was in the reservoir. [Figure 7] 1 is a graph of overlap functions over the course of a representative treatment. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0024] The term "period of aerosol generation" refers to a period of time during which the oscillatory device is primarily driven at a normal intended frequency for generating aerosol, which is typically at or near the resonant frequency (e.g., within 2 kHz of the resonant frequency). The period of aerosol generation may include a short period of time during which one or more scans are performed. The period of aerosol generation may correspond to the length of a typical patient inhalation, such as 1 s to 10 s, 2 s to 6 s, or 3 s to 5 s. The term "period of little or no aerosol generation" refers to an interval between periods of aerosol generation during which the oscillatory device is not primarily driven. The period of little or no aerosol generation may include a short period of time during which one or more scans are performed. Because most of the scan frequencies are significantly away from the resonant frequency (e.g., greater than 2 kHz), little or no aerosol is generated between scans. As a result, little or no aerosol is generated during the period of little or no aerosol generation. The period of little or no aerosol generation may correspond to a typical time between patient inhalations, such as 1 s to 10 s, 2 s to 6 s, or 3 s to 5 s. Thus, intermittently driving the vibration device (at the normal driving frequency) results in alternating periods of aerosol generation and periods of no aerosol generation.

[0025] The term "scanning" refers to the process of successively vibrating a vibration device at a number of different frequencies in stepwise increments over a defined range and measuring the value of an electrical parameter at some or all of the frequencies. The term "spectrum" refers to a graph obtained by plotting the measurements of an electrical parameter as a function of frequency. The electrical parameter may be current, voltage, power, impedance, and / or current / voltage phase shift. In particular, the electrical parameter may be the current consumption of the vibration device, the current consumption of a power conversion device providing power to the vibration device, or the voltage drop across the vibration device. These parameters may be measured by using one or more current and / or voltage sensors in a direct or indirect manner.

[0026] FIG. 1 shows an exploded view of the vibrating membrane nebulizer device described in US Pat. No. 5,999,623 and US Pat. No. 5,999,636. The device comprises three parts: a base unit, a mouthpiece part, and an aerosol head. The base unit 100 has one or more air inlet openings at its rear end (not visible in FIG. 1), an air outlet opening 102, a groove 103 for receiving the mouthpiece part 200, and one or more key lock members 104. A passage in the base unit (not visible in FIG. 1) connects the air inlet openings to the air outlet opening 102. The mouthpiece part 200 has an air inlet opening 201 that is attachable to the air outlet opening 102 of the base unit 100, a side opening 202 for receiving an aerosol generating device 301, and an aerosol outlet opening 203. A passage 205 extends from the air inlet opening 201 to the aerosol outlet opening 203. The mouthpiece 200 is insertable into the groove 103 of the base unit 100. The aerosol head 300 comprises an aerosol generating device 301, a loading chamber 302 for a liquid formulation to be aerosolized that is in fluid contact with the upper end of the aerosol generating device 301, and one or more key lock members 303 that are complementary to the key lock members 104 of the base unit 100. A lid 304 closes the loading chamber 302 to prevent contamination or leakage of the liquid during use.

[0027] The base unit 100, the mouthpiece 200, and the aerosol head 300 are removably connectable to each other. The device is assembled by inserting the mouthpiece 200 into the groove 103 in the base unit 100, then placing the aerosol head 300 on the mouthpiece 200, and engaging the key lock member 303 of the aerosol head with the key lock member 104 of the base unit by gentle pressure on both the aerosol head 300 and the base unit 100. The aerosol generating device 301 is positioned in the aerosol head 300 in such a way that when engaging the key lock member, the aerosol generating device 301 is inserted into the side opening 202 of the mouthpiece 200. This creates an airtight connection between the aerosol generating device 301 and the side opening 202 in the mouthpiece, and between the air outlet opening 102 of the base unit 100 and the air inlet opening 201 of the mouthpiece 200. The base unit 100, mouthpiece 200, and aerosol head 300 can be separated by reversing these steps.

[0028] The base unit 100 has one or more recesses 106 positioned at or near the groove 103, and the mouthpiece 200 has one or more positioning members 204. The recesses of the base unit are complementary to (i.e., shaped to receive) the positioning members of the mouthpiece. In this context, the recess is a depression whose "negative" shape is complementary to the "positive" shape of the positioning member, such as a flange or protrusion. Together, the recesses and positioning members act to accurately position the mouthpiece within the base unit. The recesses and positioning members may be asymmetric so that the mouthpiece can be inserted into the base unit in only one direction. This ensures that the device is assembled in such a way that the position and orientation of the mouthpiece and base unit relative to each other are accurate. The base unit includes a controller, such as a printed circuit board (PCB), that controls the operation of the nebulizer.

[0029] FIG. 2 shows an aerosol generating device, which is described in detail in the patent application WO 2005 / 023363. The aerosol generating device comprises a vibration device, such as a piezoelectric element 308, a transducer body 306, and a membrane 309. The piezoelectric element is preferably an annular single or multi-layer ceramic that vibrates the transducer body in a longitudinal mode. The transducer body is made, for example, from stainless steel, titanium, or aluminum, and encloses a cavity 307 that contains the liquid to be aerosolized. The inside of the filling chamber 302 is conical so that the liquid flows under gravity to the upstream end 306a of the transducer body and down into the cavity. Together, the filling chamber 302 and the cavity 307 form a reservoir for the liquid.

[0030] The membrane 309 is positioned at the downstream end 306b of the transducer body 306. The holes in the membrane can be formed by electroforming or by laser drilling, with openings typically in the range of about 1 μm to about 10 μm. In the absence of vibration of the membrane, the balance of pressure, the shape of the holes, and the nature of the material used for the membrane are such that liquid does not seep through the membrane. However, vibration of the membrane results in the formation and ejection of aerosol droplets through the holes. The membrane can be made of plastic, silicon, ceramic, or more preferably metal, and can be fixed to the downstream end of the transducer body by various means such as gluing, brazing, crimping, or laser welding. Optionally, the membrane at least partially forms a dome in its central region, which diverges the nascent jet of aerosol droplets, thereby reducing the risk of droplet coalescence.

[0031] A drive circuit 400, shown diagrammatically in FIG. 3, generates a drive signal that excites the piezoelectric element, thereby vibrating the membrane at a frequency typically in the range of 50 kHz to 200 kHz. Input DC power is provided by a battery 401. This is converted to an AC drive voltage by a power converter 402 and a transformer 403. A closed-loop controller 404 controls the power supplied to the aerosol generator 301 by pulse width modulation by varying the duty cycle, i.e., the percentage of time that power is supplied to the aerosol generator. The controller 404 inputs the drive frequency and the duty cycle to the power converter 402. The controller 404 also measures the current consumed by the aerosol generator 301 using a shunt resistor 405 in series with the input of the power converter 402. The active power consumption and absolute value of the impedance can be derived from the measured current. The aerosol generator is driven using near-resonant drive, where the frequency of the drive signal is a fixed offset (such as 500 Hz or 1 kHz) from the resonant frequency of the aerosol generator (typically around 85 kHz).

[0032] Excitation of the piezoelectric element induces longitudinal displacements and / or deformations of the order of microns in a direction parallel to the axis of symmetry of the transducer body 306. The transducer body has a region close to the piezoelectric element 308 with a relatively large wall thickness that acts as a stress concentration zone 306c, and a region downstream of it with a relatively small wall thickness that acts as a deformation amplification zone 306d. This configuration amplifies the vibration or deformation of the transducer body 306 caused by the piezoelectric element 308. The piezoelectric element 308 is positioned at or adjacent to the height of the stress concentration zone 306c. The inner diameter of the transducer body in the deformation amplification zone may be the same as the stress concentration zone, such that the difference in wall thickness corresponds to a different outer diameter. Alternatively, the outer diameter of the transducer body may be constant while the inner diameter is different at the location of the two zones.

[0033] The nebulizer is breath-activated so that aerosol is generated only when the patient is inhaling. This avoids wasting aerosol generated when the patient is exhaling, as can happen with a continuously operating nebulizer. A pressure sensor (e.g., an air pressure sensor) is positioned adjacent to and in pneumatic communication with a passageway in the base unit between the air inlet opening and the air outlet opening 102. The pressure sensor measures the pressure in the passageway and sends a signal representative of the pressure to the controller. When the patient begins to inhale at the mouthpiece, the pressure in the passageway drops. If the pressure drops below a certain value, the controller determines that the patient has begun to inhale and causes the piezoelectric element, which in turn vibrates the membrane, to generate aerosol droplets.

[0034] When the nebulizer is operated, aerosol generated by membrane 309 is released into passageway 205. Air enters through an air inlet in the base unit, passes through a passageway in the base unit, air outlet opening 102, air inlet opening 201 in the mouthpiece component, and enters passageway 205 where the air mixes with the aerosol. The air and aerosol then flow along passageway 205 and exit through aerosol outlet opening 203 in the mouthpiece to the patient's airways.

[0035] The controller stops aerosol generation when a preset length of time (e.g., 3 s) has elapsed since aerosol generation began. The preset length of time may correspond to the length of a typical inhalation and may be configurable by the patient. Alternatively, the preset length of time may be shorter than a typical inhalation, such that in the final part of the inhalation the patient receives air but not aerosol. This ensures that the aerosol reaches the central and lower parts of the patient's airways, but is not delivered to the patient's upper airways (e.g., throat), where it would be ineffective. However, the controller may alternatively detect when the patient stops inhaling by sensing a rise in pressure in the passageway, and then stop aerosol generation.

[0036] The resonant frequency of the aerosol generator changes over the duration of the treatment as the amount of liquid in the reservoir decreases. In order to maintain a fixed offset between the drive signal frequency and the resonant frequency, it is necessary to measure the resonant frequency at intervals throughout the operation of the aerosol generator, for example every 0.5 s. This is done by scanning the frequency of the drive signal over a range of frequencies from below the resonant frequency to above the resonant frequency, for example from about 10 kHz or about 15 kHz below the resonant frequency to about 10 kHz or about 15 kHz above the resonant frequency, for example from 75 kHz to about 100 kHz in steps of 0.1 kHz. At each frequency, an electrical parameter related to the oscillation of the aerosol generator is measured, for example the current consumption of the aerosol generator. The resulting graph (spectrum) of the current as a function of frequency has a peak at the resonant frequency of the aerosol generator. The scan takes, for example, about 70 ms to perform. During the scan, the aerosol generator is not operating at the optimal frequency, which reduces the aerosol output rate. As a result, almost all of the aerosol occurs in the time between scans (430 ms in this case).

[0037] The point at which the membrane has dried can be determined from a scan, e.g., from the change in the shape of the spectrum as a function of time, or by comparison to a standard spectrum, as described, for example, in U.S. Pat. Nos. 5,991,633, 5,103,721, 5,104,143, 5,105,152, and 5,200,327. However, as discussed above, these methods can produce erroneous results as a result of changes in hardware, changes in hardware over the life of the nebulizer, and changes in external conditions.

[0038] The present invention is based on a different effect that is not dependent on these changes and is therefore more reliable. When the nebulizer is switched off, the liquid in the cavity has a flat surface with a meniscus around the edge. When the nebulizer is switched on and the aerosol generator is vibrated at or near its resonant frequency, standing waves form in the liquid within about 50 ms. The opposite effect is observed when the vibration is stopped, but it takes longer (about 1 s) for the waves to dissipate and the liquid surface to become flat again.

[0039] Figure 4 shows a schematic diagram of the surface of the liquid in the reservoir of the nebulizer of Figure 1. Figure 4A shows the liquid before vibration is initiated, where the surface is flat, i.e. there is a uniform distribution of liquid across the transducer body. Figure 4B shows the surface during vibration, where the liquid forms a standing wave with a central peak.

[0040] Figures 5 and 6 show spectra obtained with the nebulizer of Figure 1 by vibrating the membrane at a series of different frequencies from 75 kHz to 100 kHz in steps of 0.1 kHz with a constant duty cycle and measuring the current consumption of the power converter at each frequency. Seven scans, each taking 70 ms, were performed with 500 ms intervals between scans. Between scans, the membrane was vibrated for 430 ms at its normal near-resonant drive frequency.

[0041] FIG. 5 shows the resulting spectrum when no liquid is present. The main peak at 89.5 kHz, where maximum current consumption occurs, is the resonant frequency of the aerosol generator. There is also a smaller peak at about 83 kHz, which is the resonant frequency of the membrane. There is no liquid present, so no standing waves are formed, and as a result, the electromechanical properties of the aerosol generator do not change during the scan. Thus, although each spectrum is plotted as a separate line, the lines overlap almost exactly with each other and it is impossible to distinguish between them.

[0042] Figure 6 shows the spectrum obtained when liquid is present. There are differences in the general shape of the spectrum compared to that of Figure 5. Firstly, the main resonance peak is at a lower frequency (86.5 kHz) and is slightly broader than in Figure 5, i.e. the resonance is slightly less sharp when liquid is present. These changes in the main resonance peak over the course of several inhalations form the basis for some known methods of empty detection. Secondly, the smaller peaks disappear.

[0043] Furthermore, in contrast to Figure 5, there are also clearly visible differences between the spectra in Figure 6 due to the redistribution of liquid due to the formation of standing waves when the aerosol generator is switched on. The resonance peaks move to slightly higher frequencies and become slightly broader in each successive spectrum. The largest difference is between the first spectrum 10 and the second spectrum 20. The third spectrum 30 and its subsequent spectra are similar to each other because the liquid has already redistributed when they were measured.

[0044] Since these changes occur only when liquid is present, they can be used to distinguish between wet and dry states of the membrane. This forms the basis of the present invention. Thus, instead of comparing measurements or spectra with preset values ​​or spectra, or comparing spectra obtained at different inhalations to identify changes occurring over the course of treatment, the present invention compares the spectrum obtained when no aerosol is generated with the spectrum obtained after aerosol generation begins. In the absence of liquid, there is no standing wave, so the spectrum before the oscillation and the spectrum during the oscillation are the same. However, when liquid is present, the spectra are different, with the first spectrum reflecting an initial flat liquid surface and the subsequent spectra reflecting standing waves.

[0045] The first spectrum in FIG. 6 (t=0s, before aerosol generation) can be compared with one (or more) of the subsequent spectra, preferably the second spectrum (t=0.5s). The effect is most clearly seen between the first and second spectra, since most of the liquid redistribution occurs quickly, typically within about 50 ms, i.e. before the second spectrum is obtained. This difference is also present when comparing the first spectrum with any subsequent spectrum. However, the spectra are also affected by the liquid fill level in the reservoir. There is little change in the fill level between the time the first spectrum is recorded and the time the second spectrum is recorded. In contrast, if the first spectrum is compared with, for example, the seventh spectrum (t=3s), the difference between them reflects a drop in the liquid fill level, as well as the formation of a standing wave. Thus, the comparison can also be made using subsequent spectra, but this is less preferred, since these spectra reflect a combination of two effects.

[0046] The degree to which two spectra match each other can be represented by an "overlap function." The overlap function can be calculated as the inverse of the sum of the absolute values ​​of the differences between the spectra at each frequency. Thus, when the spectra are different (e.g., the first and second spectra in FIG. 6), the sum of the absolute differences will be large and its inverse will be small, and thus the overlap function will have a small value. On the other hand, when the spectra are very similar (as in FIG. 5), the overlap function will have a larger value.

[0047] A representative therapeutic run was performed using the nebulizer of FIG. 1 to nebulize 4 mL of 0.9% saline. The therapeutic run consisted of 195 inhalations, i.e., approximately 20 μL of solution was nebulized in each inhalation. Aerosol generation was initiated when the patient's inhalation was detected and continued for 3 s in each inhalation. Seven scans were performed during each inhalation (t=0 s, 0.5 s, 1 s, 1.5 s, 2 s, 2.5 s, and 3 s). Each scan took 70 ms. The resonant frequency was determined from the peak in each scan. Between scans, the membrane was oscillated for 430 ms at a frequency 470 Hz higher than the resonant frequency as determined from the immediately preceding scan.

[0048] FIG. 7 shows a graph of the overlap function for each inhalation in a typical therapeutic session. The overlap function is roughly constant at small values ​​(mostly less than 1000) over the first 180 inhalations. This indicates that the first and second spectra are different in these inhalations because standing waves form in the liquid as the membrane begins to vibrate. Thereafter, the overlap function value rises sharply, indicating that the first and second spectra are more similar between 180 and 190 breaths, indicating that the effect of the standing waves is fading as little liquid remains.

[0049] A preset threshold can be used to determine when the reservoir no longer contains liquid. For example, a threshold of 5000 would be suitable in FIG. 7. The determination of when the liquid is depleted can be made more robust by only determining that the reservoir is empty if the value of the overlap function is greater than the threshold for several consecutive breaths (e.g., 3 or 5 breaths). This prevents inaccurate determinations resulting from noise or erroneous measurements in the overlap function.

[0050] Using the first and second spectra means that the overlap function can be calculated a little earlier than if subsequent spectra were used, because the time delay between the first and second spectra (0.5 s) is smaller than between the first and seventh spectra (3 s), etc. This has the advantage that the determination of when the threshold has been exceeded can be made earlier (in this example, only 2.5 s), so that the vibration of the membrane is stopped as soon as possible.

[0051] The present invention is particularly suitable for breath-actuated nebulizers, since the vibration device is necessarily operated intermittently, i.e. only when the patient inhales. The present invention can also be used with nebulizers that normally operate continuously, by introducing periods during which the vibration device is switched off. The length of the off period should be at least about 0.5 s, preferably 1 s, to allow the liquid to return to a flat surface before vibration is started again.

[0052] The overlap function in FIG. 7 is obtained by comparing the spectrum immediately before and during a period of aerosol generation, so that the difference between them reflects the formation of a standing wave when the membrane begins to oscillate. In other words, the spectrum obtained during a period of aerosol generation is compared to a spectrum obtained during a period of little or no aerosol generation that precedes it. However, the overlap function can equally be obtained by comparing a spectrum obtained during a period of aerosol generation with a spectrum obtained during a period of little or no aerosol generation that follows it. The difference between the spectrum during and after aerosol generation reflects the dissipation of the standing wave when the membrane stops oscillating. This requires that a sufficient amount of time has elapsed after the oscillations have stopped before the spectrum is measured. Typically, standing waves take longer to dissipate (500ms-1000ms) than they take to form (approximately 50ms). This is not an issue in breath-actuated inhalers, since the time between puffs is usually longer than 1s. However, in non-breath-actuated nebulizers, the periods during which the membrane is not vibrated must be longer to allow for dissipation, resulting in a reduction in the overall aerosol output rate.

[0053] The present invention is particularly suited to nebulizers of the type shown in Figure 1, in which regular scans are performed to determine the resonant frequency. The methods of the present invention can use the spectra from these scans, and additional information can be extracted from them. Thus, practicing the present invention requires only some additional analysis of the spectra, and no changes to the way the nebulizer is operated.

[0054] The principles of the invention apply to any vibrating membrane nebulizer in which the membrane is in contact with a liquid reservoir in which standing waves can be formed. The invention can therefore be used with other types of nebulizers, such as those described in, for example, US Pat. Nos. 5,993,133, 5,092,103 and 5,103,141. These nebulizers do not have a transducer in the form of a hollow tubular body. Instead, the membrane is mounted directly to the piezoelectric element or there is an annular, planar support member on which the membrane and / or the piezoelectric element are mounted.

[0055] The method of the present invention may be used in place of or in addition to other empty detection methods (such as those in US Pat. Nos. 5,993,133, 5,102,141, 5,103,152, 5,104,161, 5,105,172, 5,106,187, which measure the change in an electrical parameter as the volume of liquid decreases with time) to provide a combined decision process for determining whether the membrane is dry or not. The method of the present invention relies on an effect that is completely different from these other methods and therefore provides completely independent information about whether liquid is present or not. Thus, the combination of the method of the present invention with the different methods provides a particularly robust empty detection. [Explanation of symbols]

[0056] 10 The First Spectrum 20 The Second Spectrum 30 The Third Spectrum 100 Base Unit 102 Air outlet opening 103 Groove 104 Key lock member 106 Recess 200 Mouthpiece parts 201 Air inlet opening 202 Side opening 203 Aerosol exit opening 204 Positioning member 205 Aisle 300 Aerosol Head 301 Aerosol Generator 302 Filling room 303 Key lock parts 304 Lid 306 Converter body 306a Upstream end 306b downstream end 306c Stress concentration zone 306d Zone 307 Cavity 308 Piezoelectric Elements 309 Membrane 400 Drive circuit 401 Batteries 402 Power conversion equipment 403 Transformer 404 Closed Loop Control Device 405 shunt resistor

Claims

1. 1. A breath actuated inhalation device comprising: an aerosol generating device having a vibration device and a membrane; a reservoir for a liquid to be aerosolized in fluid communication with the membrane; and a controller providing a drive signal to drive the vibration device such that the membrane vibrates to generate an aerosol, the controller comprising: intermittently driving the vibration device such that the aerosol generating device alternates between periods of aerosol generation during a patient's inhalation and periods of little or no aerosol generation before and / or after said inhalation; vibrating the membrane at a plurality of frequencies and performing a scan in which at least one electrical parameter of the vibrating device is measured at the plurality of frequencies to provide a spectrum, the scan being performed during the inhalation and during the period before or after the inhalation; comparing a spectrum obtained during inhalation with a spectrum obtained during said period before or after said inhalation; determining whether liquid is present in the reservoir based on the comparison of the spectra; and ceasing to activate the vibration device if the controller determines that no liquid is present; and The inhalation device is configured to:

2. 2. The inhalation device of claim 1, wherein the control device is configured to perform a first scan before each inhalation to obtain a first spectrum, subsequently perform a second scan during each inhalation to obtain a second spectrum, and compare the first spectrum with the second spectrum.

3. The inhalation device of claim 1 or 2, comprising a passage having an air inlet opening and an aerosol outlet opening, and a pressure sensor pneumatically connected to the passage, and the control device is configured to detect inhalation by a patient at the aerosol outlet opening based on a signal from the pressure sensor, and to initiate a period of aerosol generation in response to the inhalation.

4. 4. The inhalation device of claim 3, wherein the controller is configured to initiate a period of little or no aerosol generation at a preset time after the period of aerosol generation has begun.

5. 5. The inhalation device according to claim 1, wherein the aerosol generating device has a support member comprising a hollow tubular body having a flange at or near a first end to which the vibration device is attached and a second end to which the membrane is mounted, and the inhalation device has a filling chamber above the support member such that the filling chamber and the hollow tubular body together form the reservoir.

6. An inhalation device as described in any one of claims 1 to 5, wherein the control device is configured to determine a resonant frequency of the aerosol generating device from the spectrum and to drive the vibration device at the resonant frequency or at a frequency related to the resonant frequency during a period of the aerosol generation other than the scanning.

7. 7. The inhalation device of claim 6, wherein the plurality of frequencies includes frequencies from about 10 kHz or about 15 kHz lower than the resonant frequency to about 10 kHz or about 15 kHz higher than the resonant frequency.

8. The inhalation device of claim 7, wherein the multiple frequencies include from 75 kHz to approximately 100 kHz.

9. An inhalation device according to any one of claims 1 to 8, wherein the control unit is configured to compare the spectra by calculating an overlap function.

10. 10. The inhalation device of claim 9, wherein the controller is configured to determine that no liquid is present in the reservoir if the overlap function is above a threshold.

11. 11. The inhalation device of claim 10, wherein the control device is configured to stop driving the vibration device if the overlap function exceeds the threshold for a period of multiple consecutive aerosol generations.

12. The inhalation device of claim 11, wherein the control device is configured to stop driving the vibration device if the overlap function exceeds the threshold for a period of three or five consecutive aerosol generations.

Citation Information

Patent Citations

  • Inhalation device for use in aerosol therapy

    EP2724741A1

  • Identification of dry nebulizer elements

    JP2013517099A

  • Control and monitor nebulizer vibrating aperture plate drive frequency

    JP2016536124A

  • Aerosol delivery device and method of operating the aerosol delivery device

    JP2017502742A

  • Inhalation therapy device

    US20060102172A1